Literature DB >> 2529439

Erythema nodosum after Recombivax HB hepatitis B vaccine.

P L Goolsby.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2529439     DOI: 10.1056/NEJM198910263211717

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Vasculitis related to hepatitis B vaccine.

Authors:  P Cockwell; M B Allen; R Page
Journal:  BMJ       Date:  1990-12-01

2.  Hepatitis B vaccine associated with erythema nodosum and polyarthritis.

Authors:  S J Rogerson; F J Nye
Journal:  BMJ       Date:  1990-08-11

3.  Combined reduced-antigen content tetanus, diphtheria, and acellular pertussis (tdap) vaccine-related erythema nodosum: case report and review of vaccine-associated erythema nodosum.

Authors:  Philip R Cohen
Journal:  Dermatol Ther (Heidelb)       Date:  2013-11-01

4.  First Case of Erythema Nodosum Associated With Pfizer Vaccine.

Authors:  Mohammed H Aly; Abdulrahman A Alshehri; Abdelgaffar Mohammed; Abdulrahman M Almalki; Walaa A Ahmed; Alhanouf M Almuflihi; Atheer A Alwafi
Journal:  Cureus       Date:  2021-11-13

5.  Change in adverse event reporting following immunization of hepatitis B vaccine among infants between 2013 to 2020 before and after the vaccine administration law in China.

Authors:  Chao Wang; Ninghua Huang; Qing-Bin Lu; Steven Black; Xiaofeng Liang; Fuqiang Cui
Journal:  Front Immunol       Date:  2022-09-30       Impact factor: 8.786

6.  Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.

Authors:  Yimin Wu; Ruth D Ellis; Donna Shaffer; Erica Fontes; Elissa M Malkin; Siddhartha Mahanty; Michael P Fay; David Narum; Kelly Rausch; Aaron P Miles; Joan Aebig; Andrew Orcutt; Olga Muratova; Guanhong Song; Lynn Lambert; Daming Zhu; Kazutoyo Miura; Carole Long; Allan Saul; Louis H Miller; Anna P Durbin
Journal:  PLoS One       Date:  2008-07-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.